EMEA-001951-PIP01-16

Key facts

Active substance
Pegvaliase
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/0036/2017
PIP number
EMEA-001951-PIP01-16
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of hyperphenylalaninaemia
Route(s) of administration
Subcutaneous use
Contact for public enquiries
BioMarin International Limited

Tel. +44 2074200800
E-mail: biomarin-europe@bmrn.com

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating